In Vivo Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell Therapy

Adoptive cell therapy (ACT) using autologous tumor infiltrating lymphocytes (TIL) achieves durable clinical benefit for patients from whom these cells can be derived in advanced metastatic melanoma but is limited in most solid tumors as a result of immune escape and exclusion. A tumor microenvironme...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Immunol
Huvudupphovsmän: Giehl, Esther, Kosaka, Hiromichi, Liu, Zuqiang, Feist, Mathilde, Kammula, Udai S., Lotze, Michael T., Ma, Congrong, Guo, Zong Sheng, Bartlett, David L.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2021
Ämnen:
Immunology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7930493/
https://ncbi.nlm.nih.gov/pubmed/33679747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.610042
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk